Search results for: NHS Expenditure
Filter search results
OHE’s Towse on Challenges in Valuing Genomic Medicines
23 May 2013
…view other videos from the Translation Genomics Event presented by the NHS’s National Genetics Education and Development Centre click here. Challenges in Valuing Genomic Medicines from Office of Health Economics…
19th Annual Lecture: What Constitutes Credible Evidence of Effectiveness?
4 June 2013
…19th OHE annual lecture. London: Office of Health Economics. The 2013 OHE Annual Lecture, scheduled for 16 July, will address quality in the NHS and be given by Professor Alan…
Forecasting the Challenges and Economics of Drug Development in 2022
9 July 2013
…unique resources of the NHS and creating vigorous clusters of research excellence. OHE’s Director, Prof. Adrian Towse, said ‘What struck me most about the conference discussions was the clear consensus…
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
…clinical value. One approach would be NHS use of diagnostic kits with an evidence base in preference to in-house tests with no such evidence base. The report also emphasises the…
Dr Fraser Lewis Joins OHE as Head of Statistics
17 September 2013
…experience in applied biostatistics in a range of research environments, including in the NHS in Scotland, at the University of Edinburgh and in a contract research organisation. Fraser has been principal investigator on his own…
Seminar Updates Project on Time Lags in Medical Research
8 October 2013
…history of each technology from early basic research and discovery through to routine use in the NHS and other health care systems. At a recent OHE lunchtime seminar, Jonathan Grant…
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
…cost-effectiveness threshold should be set equal to the budget decrease that would cause the NHS to produce one less QALY. However, it argues that the £12,936 estimate has two serious…
Social Preferences and Burden of Illness in Value-based Assessments
11 February 2014
…the NHS, allowing the authors to calculate the strength of any social preference for providing health care to the sickest patients first. The research is intended to inform changes in…
The Expanding Value Footprint of Oncology Treatments
13 May 2014
…resulted in a recommendation against use in the NHS. The statistics for Aetna are more difficult to interpret because the company may elect to reimburse for uses that have not…